Evidence map›Paper›PMID 26421924›Full record

ArticlePLoS pathogens2015

Conserved Motifs within Hepatitis C Virus Envelope (E2) RNA and Protein Independently Inhibit T Cell Activation.

Nirjal Bhattarai, James H McLinden, Jinhua Xiang, Thomas M Kaufman, Jack T Stapleton

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nirjal BhattaraiResearch Service and, The Iowa City Veterans Affairs Medical Center, Iowa City, Iowa, United States of America; The Departments of Internal Medicine and Microbiology, University of Iowa, Iowa City, Iowa, United States of America.
James H McLindenResearch Service and, The Iowa City Veterans Affairs Medical Center, Iowa City, Iowa, United States of America; The Departments of Internal Medicine and Microbiology, University of Iowa, Iowa City, Iowa, United States of America.
Jinhua XiangResearch Service and, The Iowa City Veterans Affairs Medical Center, Iowa City, Iowa, United States of America; The Departments of Internal Medicine and Microbiology, University of Iowa, Iowa City, Iowa, United States of America.
Thomas M KaufmanResearch Service and, The Iowa City Veterans Affairs Medical Center, Iowa City, Iowa, United States of America; The Departments of Internal Medicine and Microbiology, University of Iowa, Iowa City, Iowa, United States of America.
Jack T StapletonResearch Service and, The Iowa City Veterans Affairs Medical Center, Iowa City, Iowa, United States of America; The Departments of Internal Medicine and Microbiology, University of Iowa, Iowa City, Iowa, United States of America.
University of Iowa · USVeterans Health Administration · US

Funding

The effects of hepatitis C virus (HCV) E2 protein on host immunomodulationI01BX000207 · VA · IOWA CITY VA MEDICAL CENTER · PI STAPLETON, JACK T. · 2009 to 2025
–
BLRD VA I01 BX000207BLRD VA I01 BX001241CSRD VA I01 CX000821
6 · The paper itself

Abstract

T cell receptor (TCR) signaling is required for T-cell activation, proliferation, differentiation, and effector function. Hepatitis C virus (HCV) infection is associated with impaired T-cell function leading to persistent viremia, delayed and inconsistent antibody responses, and mild immune dysfunction. Although multiple factors appear to contribute to T-cell dysfunction, a role for HCV particles in this process has not been identified. Here, we show that incubation of primary human CD4+ and CD8+ T-cells with HCV RNA-containing serum, HCV-RNA containing extracellular vesicles (EVs), cell culture derived HCV particles (HCVcc) and HCV envelope pseudotyped retrovirus particles (HCVpp) inhibited TCR-mediated signaling. Since HCVpp's contain only E1 and E2, we examined the effect of HCV E2 on TCR signaling pathways. HCV E2 expression recapitulated HCV particle-induced TCR inhibition. A highly conserved, 51 nucleotide (nt) RNA sequence was sufficient to inhibit TCR signaling. Cells expressing the HCV E2 coding RNA contained a short, virus-derived RNA predicted to be a Dicer substrate, which targeted a phosphatase involved in Src-kinase signaling (PTPRE). T-cells and hepatocytes containing HCV E2 RNA had reduced PTPRE protein levels. Mutation of 6 nts abolished the predicted Dicer interactions and restored PTPRE expression and proximal TCR signaling. HCV RNA did not inhibit distal TCR signaling induced by PMA and Ionomycin; however, HCV E2 protein inhibited distal TCR signaling. This inhibition required lymphocyte-specific tyrosine kinase (Lck). Lck phosphorylated HCV E2 at a conserved tyrosine (Y613), and phospho-E2 inhibited nuclear translocation of NFAT. Mutation of Y613 restored distal TCR signaling, even in the context of HCVpps. Thus, HCV particles delivered viral RNA and E2 protein to T-cells, and these inhibited proximal and distal TCR signaling respectively. These effects of HCV particles likely aid in establishing infection and contribute to viral persistence.

Indexed as

Base SequenceConserved SequenceEnzyme-Linked Immunosorbent AssayFlow CytometryHepacivirusHepatitis CHumansImmunoblottingImmunoprecipitationLymphocyte ActivationPolymerase Chain ReactionReceptors, Antigen, T-CellRNA, ViralT-LymphocytesViral Envelope ProteinsVirionglycoprotein E2, Hepatitis C virusReceptors, Antigen, T-CellRNA, ViralViral Envelope Proteins

Identifiers

PMID26421924
PMCPMC4589396
OpenAlexW2208788834

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.